Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD, Talbot JA, Chomyc S, Davison E, Singer J, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG. Shafran SD, et al. Among authors: gill mj. Clin Infect Dis. 1998 Dec;27(6):1401-5. doi: 10.1086/515022. Clin Infect Dis. 1998. PMID: 9868650 Clinical Trial.
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome.
Austin J, Singhal N, Voigt R, Smaill F, Gill MJ, Walmsley S, Salit I, Gilmour J, Schlech WF 3rd, Choudhri S, Rachlis A, Cohen J, Trottier S, Toma E, Phillips P, Ford PM, Woods R, Singer J, Zarowny DP, Cameron DW; CTN 091/CRIT Cartenoids Study Group. Austin J, et al. Among authors: gill mj. Eur J Clin Nutr. 2006 Nov;60(11):1266-76. doi: 10.1038/sj.ejcn.1602447. Epub 2006 May 24. Eur J Clin Nutr. 2006. PMID: 16721396 Clinical Trial.
Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian randomized MAC treatment trial. Canadian HIV Trials Network Protocol 010 Study Group.
Singer J, Thorne A, Phillips P, Rachlis AR, Miller M, Gill MJ, Smaill FM, Schlech WF 3rd, Senay H, Shafran SD. Singer J, et al. Among authors: gill mj. AIDS. 1999 Apr 1;13(5):575-82. doi: 10.1097/00002030-199904010-00006. AIDS. 1999. PMID: 10203382 Clinical Trial.
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. Shafran SD, et al. Among authors: gill mj. N Engl J Med. 1996 Aug 8;335(6):377-83. doi: 10.1056/NEJM199608083350602. N Engl J Med. 1996. PMID: 8676931 Free article. Clinical Trial.
Therapy for recurrent herpetic whitlow.
Gill MJ, Arlette J, Buchan K, Tyrrell DL. Gill MJ, et al. Ann Intern Med. 1986 Oct;105(4):631. doi: 10.7326/0003-4819-105-4-631_1. Ann Intern Med. 1986. PMID: 3752779 No abstract available.
Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency.
Tsoukas CM, Raboud J, Bernard NF, Montaner JS, Gill MJ, Rachlis A, Fong IW, Schlech W, Djurdjev O, Freedman J, Thomas R, Lafrenière R, Wainberg MA, Cassol S, O'Shaughnessy M, Todd J, Volvovitz F, Smith GE. Tsoukas CM, et al. Among authors: gill mj. AIDS Res Hum Retroviruses. 1998 Apr 10;14(6):483-90. doi: 10.1089/aid.1998.14.483. AIDS Res Hum Retroviruses. 1998. PMID: 9566550 Clinical Trial.
427 results